Navigation Links
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
Date:6/17/2009

- 12 week progression free rate supports advancement into second stage of Simon 2-Stage designed trial -

BRANFORD, Conn., June 17 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) announced today that its Phase I/II Trial evaluating CR011-vcMMAE for the treatment of patients with advanced breast cancer has met the efficacy criteria for advancement to the second stage of enrollment. To date, 29 patients have been enrolled in this trial, including 15 in the Phase II portion. Two of the first four evaluable Phase II patients were progression-free at 12 weeks, therefore, as part of the Simon 2-Stage design, the Phase II trial will now advance to the second stage and enroll a total of approximately 25 patients. The principal investigator of the study is Dr. Linda Vahdat, Medical Director of the Breast Cancer Research Program and Associate Professor of Clinical Medicine, /Weill Cornell. CuraGen anticipates presenting updated results from this study during the second half of 2009.

About CR011-vcMMAE

CR011-vcMMAE is an antibody-drug conjugate (ADC) being developed by CuraGen that consists of a fully-human monoclonal antibody, CR011, linked to a potent cell-killing drug, monomethyl-auristatin E (MMAE). The ADC technology, comprised of MMAE and a stable linker system for attaching it to CR011, was licensed from Seattle Genetics, Inc. The ADC is designed to be stable in the bloodstream. Following intravenous administration, CR011-vcMMAE targets and binds to GPNMB, a specific protein that is predominantly expressed on the surface of cancer cells, including melanoma, breast cancer and glioma. Upon internalization by the targeted cell, CR011-vcMMAE is designed to release MMAE from CR011 to produce a cell-killing effect. CR011-vcMMAE is currently in two Phase II trials assessing its safety and efficacy in the
'/>"/>

SOURCE CuraGen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CuraGen Updates CR011-vcMMAE Data at ASCO
2. CuraGen to Present CR011-vcMMAE Data at ASCO
3. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
4. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
5. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
6. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
7. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
8. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
9. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
10. CuraGen Advances CR011-vcMMAE into Phase II
11. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ...  to their offering.       ... or gene silencing involves the use of ... cell, this material is processed into short ...
(Date:5/28/2015)... Colo. , May 28, 2015 ... providers of cartilage, cellular, bone, skin and soft-tissue ... care to advance patient healing, today announced that ... has been moved to the high-cost reimbursement category. ... allografts reach doctors and their patients," said ...
(Date:5/28/2015)... May 28, 2015 ... the addition of the  "North America Ultrasound ... (2014 - 2019)"  report to their offering.  ... Ultrasound is a type of imaging. It ... body parts and structures inside the body. ...
Breaking Medicine Technology:Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2
... Medical, Inc. a Texas based medical device manufacturer with ... manufacturing operations in Golden, Colorado, announced today that it ... a Nitinol Inferior Vena Cava (IVC) filter, permanently attached ... of preventing Pulmonary Embolism (PE) in critically ill patients. ...
... Pa., May 15, 2012 Millennium Surgical Corp. continues ... Sales activity increased in the third quarter of 2011 ... number of new clients for the first four months ... in FY2011. To accommodate additional clients and the increasing ...
Cached Medicine Technology:Millennium Surgical Corp. Announces Sales Figures, Growth 2
(Date:5/28/2015)... Dallas, Texas (PRWEB) May 28, 2015 Park ... 2” Group Dog Training class starting Saturday, June ... in the courtyard of 5831 McCommas Blvd in Dallas, with ... The classes will run for five weeks, with no class ... for the class is $135. , In this Intermediate-to-Advanced level ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 Three years ... new location for his Shore Vascular & Vein Center! ... the circulatory system. It is his mission to provide ... and respect. , Dr. Jeffrey Gosin is Board ... of the University of Pennsylvania and Jefferson Medical College. He ...
(Date:5/28/2015)... AMVETS leaders this week congratulated AMVETS ... Davis of Newark, Del. AMVETS National Commander Larry Via ... the $10,000 sweepstakes grand prize. , AMVETS selected the ... around the country for prizes ranging from $500 to ... May 21 at the AMVETS National Headquarters in Lanham, ...
(Date:5/28/2015)... Medelis, Inc., a specialty oncology CRO ... in the role of president. , “ Bill Taaffe ... industry,” said Larry Flanagan, Medelis’ CEO and co-founder. “He will ... next phase of growth.” , Taaffe joined ICON’s U.S. ... employees to over 4,500 employees, achieving 12 consecutive years of ...
(Date:5/28/2015)... 28, 2015 ISMETT , a leading ... boosted the Sicilian economy by €132.5 million in expenditure in ... of more than €73 million by retaining patients who otherwise ... a new study by the Battelle Memorial Institute. At the ... training and advanced health care management that is transforming Sicily ...
Breaking Medicine News(10 mins):Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3
... years to life, researchers say , WEDNESDAY, Sept. 23 ... diabetes, obesity and high blood pressure improves the lives ... findings show. , Researchers looked at a group of ... their future state of health and medical costs if ...
... , , , SAN DIEGO, ... that it has reached an agreement with Sunshine Specialties of California. ... assists Natural Product companies in increasing brand awareness and market penetration ... Victor Brandstetter, VP of Sales of US Farms, Inc. ...
... , MANCHESTER, N.H., Sept. 23 ... 50 years making lives easier with its innovative products, today ... brand EVAPTEX(TM). EVAPTEX(TM) fabric is a woven high-performance breathable textile ... air to circulate through while keeping the fabric temperature-neutral for ...
... of cases with commentaries by the American College ... Committee and the College,s Center for Ethics and ... "The ethical dilemmas presented are very relevant ... FACP, ACP President. "Learning from case studies can ...
... ... Career College for unwavering commitment , ... Vancouver, BC (Vocus) September 23, 2009 -- Every September, thousands of BC students enroll ... careers. For a large number of them, student life will bring a host of challenges ...
... , PRINCETON, N.J., Sept. 23 ... carry condoms, the makers of Trojan(R) Brand Condoms recently introduced Trojan ... plastic case. The new product, which is designed to stand-up to ... counters of many food, drug and convenience retail locations, making Trojan ...
Cached Medicine News:Health News:Cost Savings Adds to Value of Preventing Chronic Disease 2Health News:US Farms, Inc. Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 2Health News:US Farms, Inc. Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 3Health News:Breathing is No Sweat with New VELCRO(R) Brand EVAPTEX(TM) High-Performance Fabric 2Health News:Breathing is No Sweat with New VELCRO(R) Brand EVAPTEX(TM) High-Performance Fabric 3Health News:Focused Learning Environment Guides Student Success 2Health News:Focused Learning Environment Guides Student Success 3Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 2Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 3Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: